We first used the web-based tool Kaplan-Meier plotter (50) to assess the correlation between RET mRNA expression and overall survival (OS) and relapse-free survival (RFS) in a cohort of ER+ breast cancer patients receiving endocrine treatment in the primary setting. This evidence concerns the gene ESR1 and breast carcinoma.